SkinBioTherapeutics plc (AIM: SBTX)
London
· Delayed Price · Currency is GBP · Price in GBX 17.60
-0.03 (-0.14%)
Jan 21, 2025, 2:29 PM GMT+1
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 39.98 million as of January 22, 2025. Its market cap has increased by 31.25% in one year.
Market Cap
39.98M
Enterprise Value
39.99M
Revenue
1.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.60
Market Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 39.98M, an increase of 154.16%. That is a compound annual growth rate of 12.70%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 169.60B |
| GSK plc | 55.25B |
| Haleon | 33.80B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.95B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 2.00B |
| Oxford Nanopore Technologies | 1.37B |